Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David John Kuter, M.D., DR.PHIL.

Title
Institution
Department
Address
Phone
Fax
Other Positions
Title
Institution
Department

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01HL082889 (KUTER, DAVID J) Sep 15, 2005 - Feb 28, 2010
    NIH/NHLBI
    A Proteogenomic Analysis of Platelets in Patients with Essential Thrombocythemia
    Role: Principal Investigator
  2. U01HL072299 (KUTER, DAVID J) Sep 30, 2002 - Aug 31, 2014
    NIH/NHLBI
    MGH Transfusion Medicine and Hemostasis Network Clinical Core Center
    Role: Principal Investigator
  3. R01HL061222 (KUTER, DAVID J) Sep 30, 1998 - Aug 31, 2002
    NIH/NHLBI
    MOLECULAR AND CELLULAR MECHANISMS OF PLATELET VIABILITY
    Role: Principal Investigator
  4. R01HL054838 (KUTER, DAVID J) Aug 15, 1995 - Jul 31, 2000
    NIH/NHLBI
    MOLECULAR PHYSIOLOGY OF THROMBOPOIETIN
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Mehta A, Kuter DJ, Salek SS, Belmatoug N, Bembi B, Bright J, Vom Dahl S, Deodato F, Di Rocco M, Göker-Alpan O, Hughes DA, Lukina EA, Machaczka M, Mengel E, Nagral A, Nakamura K, Narita A, Oliveri B, Pastores G, Pérez-López J, Ramaswami U, Schwartz IV, Szer J, Weinreb NJ, Zimran A. Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative. Intern Med J. 2019 May; 49(5):578-591. PMID: 30414226.
    Citations:    Fields:    
  2. Al-Samkari H, Kuter DJ. Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia. Ther Adv Hematol. 2019; 10:2040620719841735. PMID: 31007886.
    Citations:    
  3. Kuter D, Suárez L, Dodd EL, Noll BC, Stephens PW, Bohle DS. Hydrating the Bispropionate Notch in Malaria Pigment: A New Structural Motif in the Iron(III)(deuteroporphyrin) Dimer. Chemistry. 2019 Mar 21; 25(17):4373-4378. PMID: 30499153.
    Citations:    
  4. Kuter DJ, Newland A, Chong BH, Rodeghiero F, Romero MT, Pabinger I, Chen Y, Wang K, Mehta B, Eisen M. Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies. Br J Haematol. 2019 May; 185(3):503-513. PMID: 30793285.
    Citations:    
  5. Guddati AK, Rosovsky RP, Van Cott EM, Kuter DJ. Quantitative analysis of desmopressin (DDAVP) response in adult patients with type 1 von Willebrand disease. Int J Lab Hematol. 2019 Jun; 41(3):325-330. PMID: 30735311.
    Citations:    
  6. Al-Samkari H, Patel AA, Schiano TD, Kuter DJ. Recurrence of Acute Intermittent Porphyria After Liver Transplantation. Ann Intern Med. 2019 Feb 05. PMID: 30716770.
    Citations:    
  7. Bianchi P, Fermo E, Glader B, Kanno H, Agarwal A, Barcellini W, Eber S, Hoyer JD, Kuter DJ, Maia TM, Mañu-Pereira MDM, Kalfa TA, Pissard S, Segovia JC, van Beers E, Gallagher PG, Rees DC, van Wijk R. Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency. Am J Hematol. 2019 Jan; 94(1):149-161. PMID: 30358897.
    Citations:    Fields:    
  8. Al-Samkari H, Van Cott EM, Kuter DJ. Platelet aggregation response in immune thrombocytopenia patients treated with romiplostim. Ann Hematol. 2019 Mar; 98(3):581-588. PMID: 30446804.
    Citations:    Fields:    
  9. Rosen EA, Vallurupalli M, Choy E, Lennerz JK, Kuter DJ. Management of disseminated intravascular coagulation in a patient with hepatic angiosarcoma: A case report. Medicine (Baltimore). 2018 Nov; 97(47):e13321. PMID: 30461646.
    Citations:    Fields:    Translation:Humans
  10. Nagrebetsky A, Al-Samkari H, Davis NM, Kuter DJ, Wiener-Kronish JP. Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies. Br J Anaesth. 2019 Jan; 122(1):19-31. PMID: 30579402.
    Citations:    Fields:    
  11. Al-Samkari H, Kritharis A, Rodriguez-Lopez JM, Kuter DJ. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia. J Intern Med. 2019 Feb; 285(2):223-231. PMID: 30191646.
    Citations:    Fields:    
  12. Al-Samkari H, Kritharis A, Kuter DJ. Infections and vaccination in hereditary hemorrhagic telangiectasia: microbiological evidence-based considerations. Haematologica. 2018 Oct; 103(10):e492-e495. PMID: 30270207.
    Citations:    Fields:    
  13. Al-Samkari H, Kuter DJ. Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia. Am J Hematol. 2018 Dec; 93(12):1501-1508. PMID: 30187942.
    Citations:    Fields:    
  14. Kuter DJ, Allen LF. Avatrombopag, an oral thrombopoietin receptor agonist: results of two double-blind, dose-rising, placebo-controlled Phase 1 studies. Br J Haematol. 2018 Nov; 183(3):466-478. PMID: 30203841.
    Citations:    
  15. Al-Samkari H, Kuter DJ. An alternative intermittent eltrombopag dosing protocol for the treatment of chronic immune thrombocytopenia. Br J Clin Pharmacol. 2018 Nov; 84(11):2673-2677. PMID: 30032487.
    Citations: 1     Fields:    
  16. Ismailova A, Kuter D, Bohle DS, Butler IS. An Overview of the Potential Therapeutic Applications of CO-Releasing Molecules. Bioinorg Chem Appl. 2018; 2018:8547364. PMID: 30158958.
    Citations:    
  17. Al-Samkari H, Kuter DJ. Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia. Br J Haematol. 2018 Oct; 183(2):168. PMID: 29978577.
    Citations:    Fields:    
  18. Kritharis A, Al-Samkari H, Kuter DJ. Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective. Haematologica. 2018 09; 103(9):1433-1443. PMID: 29794143.
    Citations: 2     Fields:    
  19. Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. Romiplostim for the management of perioperative thrombocytopenia. Br J Haematol. 2018 07; 182(1):106-113. PMID: 29767837.
    Citations:    Fields:    
  20. Regenboog M, van Dussen L, Verheij J, Weinreb NJ, Santosa D, Vom Dahl S, Häussinger D, Müller MN, Canbay A, Rigoldi M, Piperno A, Dinur T, Zimran A, Mistry PK, Salah KY, Belmatoug N, Kuter DJ, Hollak CEM. Hepatocellular carcinoma in Gaucher disease: an international case series. J Inherit Metab Dis. 2018 Sep; 41(5):819-827. PMID: 29423829.
    Citations:    Fields:    
  21. Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors. Haematologica. 2018 04; 103(4):e169-e172. PMID: 29242295.
    Citations:    Fields:    
  22. Crawford J, Becker PS, Armitage JO, Blayney DW, Chavez J, Curtin P, Dinner S, Fynan T, Gojo I, Griffiths EA, Hough S, Kloth DD, Kuter DJ, Lyman GH, Mably M, Mukherjee S, Patel S, Perez LE, Poust A, Rampal R, Roy V, Rugo HS, Saad AA, Schwartzberg LS, Shayani S, Talbott M, Vadhan-Raj S, Vasu S, Wadleigh M, Westervelt P, Burns JL, Pluchino L. Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 12; 15(12):1520-1541. PMID: 29223990.
    Citations: 3     Fields:    Translation:HumansCells
  23. Mehta A, Belmatoug N, Bembi B, Deegan P, Elstein D, Göker-Alpan Ö, Lukina E, Mengel E, Nakamura K, Pastores GM, Pérez-López J, Schwartz I, Serratrice C, Szer J, Zimran A, Di Rocco M, Panahloo Z, Kuter DJ, Hughes D. Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians. Mol Genet Metab. 2017 11; 122(3):122-129. PMID: 28847676.
    Citations: 1     Fields:    Translation:Humans
  24. Fitzroy SM, Gildenhuys J, Olivier T, Tshililo NO, Kuter D, de Villiers KA. The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated ß-Hematin Crystallization. Langmuir. 2017 08 01; 33(30):7529-7537. PMID: 28689414.
    Citations:    Fields:    Translation:AnimalsCells
  25. Kuter DJ, Konkle BA, Hamza TH, Uhl L, Assmann SF, Kiss JE, Kaufman RM, Key NS, Sachais BS, Hess JR, Ness P, McCrae KR, Leissinger C, Strauss RG, McFarland JG, Neufeld E, Bussel JB, Ortel TL. Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia. Am J Hematol. 2017 Aug; 92(8):730-738. PMID: 28388835.
    Citations: 1     Fields:    Translation:Humans
  26. Kuter DJ. What is the role of novel thrombopoietic agents in the management of acute leukemia? Best Pract Res Clin Haematol. 2016 12; 29(4):372-378. PMID: 27890262.
    Citations:    Fields:    Translation:Humans
  27. Marshall AL, Scarpone R, De Greef M, Bird R, Kuter DJ. Remissions after long-term use of romiplostim for immune thrombocytopenia. Haematologica. 2016 12; 101(12):e476-e478. PMID: 27587382.
    Citations:    Fields:    Translation:Humans
  28. Lubberts B, Paulino Pereira NR, Kabrhel C, Kuter DJ, DiGiovanni CW. What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis. Thromb Haemost. 2016 08 30; 116(3):417-31. PMID: 27362694.
    Citations: 3     Fields:    Translation:Humans
  29. Kim PG, Suh J, Adelman MW, Oduro K, Williams E, Brunner AM, Kuter DJ. Pure White Cell Aplasia and Necrotizing Myositis. Case Rep Hematol. 2016; 2016:4161679. PMID: 27073704.
    Citations:    
  30. Gildenhuys J, Sammy CJ, Müller R, Streltsov VA, le Roex T, Kuter D, de Villiers KA. Alkoxide coordination of iron(III) protoporphyrin IX by antimalarial quinoline methanols: a key interaction observed in the solid-state and solution. Dalton Trans. 2015 Oct 14; 44(38):16767-77. PMID: 26335948.
    Citations: 2     Fields:    Translation:Cells
  31. Kuter D, Streltsov V, Davydova N, Venter GA, Naidoo KJ, Egan TJ. Solution structures of chloroquine-ferriheme complexes modeled using MD simulation and investigated by EXAFS spectroscopy. J Inorg Biochem. 2016 Jan; 154:114-25. PMID: 26088729.
    Citations: 1     Fields:    Translation:Cells
  32. Marshall AL, Goodarzi K, Kuter DJ. Romiplostim in the management of the thrombocytopenic surgical patient. Transfusion. 2015 Oct; 55(10):2505-10. PMID: 26033367.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  33. Kuter DJ. Managing thrombocytopenia associated with cancer chemotherapy. Oncology (Williston Park). 2015 Apr; 29(4):282-94. PMID: 25952492.
    Citations: 12     Fields:    Translation:Humans
  34. Kuter DJ, Macahilig C, Grotzinger KM, Poston SA, Wang PF, Dawson KL, Ward M. Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim. Int J Hematol. 2015 Mar; 101(3):255-63. PMID: 25586660.
    Citations: 7     Fields:    Translation:Humans
  35. Kuter D, Streltsov V, Davydova N, Venter GA, Naidoo KJ, Egan TJ. Molecular structures and solvation of free monomeric and dimeric ferriheme in aqueous solution: insights from molecular dynamics simulations and extended X-ray absorption fine structure spectroscopy. Inorg Chem. 2014 Oct 20; 53(20):10811-24. PMID: 25275882.
    Citations:    Fields:    Translation:Cells
  36. Kuter DJ, Meibohm A, Lopez A. TPO concentrations and response to romiplostim. Am J Hematol. 2014 Dec; 89(12):1155-6. PMID: 25132329.
    Citations:    Fields:    Translation:Humans
  37. Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19; 123(25):3887-94. PMID: 24802775.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  38. Guddati AK, Kuter DJ. Rituximab therapy for factor II inhibitor in a patient with antiphospholipid antibody syndrome. Blood Coagul Fibrinolysis. 2014 Apr; 25(3):289-91. PMID: 24448153.
    Citations:    Fields:    Translation:Humans
  39. Kuter DJ. Milestones in understanding platelet production: a historical overview. Br J Haematol. 2014 Apr; 165(2):248-58. PMID: 24528208.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  40. Kuter D, Benjamin SJ, Egan TJ. Multiple spectroscopic and magnetic techniques show that chloroquine induces formation of the µ-oxo dimer of ferriprotoporphyrin IX. J Inorg Biochem. 2014 Apr; 133:40-9. PMID: 24480793.
    Citations: 2     Fields:    Translation:HumansCells
  41. Crawford J, Armitage J, Balducci L, Becker PS, Blayney DW, Cataland SR, Heaney ML, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Rugo HS, Saad AA, Schwartzberg LS, Shayani S, Steensma DP, Talbott M, Vadhan-Raj S, Westervelt P, Westmoreland M, Dwyer M, Ho M. Myeloid growth factors. J Natl Compr Canc Netw. 2013 Oct 01; 11(10):1266-90. PMID: 24142827.
    Citations: 19     Fields:    Translation:Humans
  42. Makar RS, Zhukov OS, Sahud MA, Kuter DJ. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists. Am J Hematol. 2013 Dec; 88(12):1041-4. PMID: 23913253.
    Citations: 6     Fields:    Translation:Humans
  43. Kuter DJ. The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol. 2013 Jul; 98(1):10-23. PMID: 23821332.
    Citations: 28     Fields:    Translation:HumansAnimalsCells
  44. Fitzsimons MG, Walton K, Makar R, Dzik W, Kuter D, Vlahakes GJ. Redo aortic valve replacement in a patient with immunoglobulin A deficiency and hemophilia A. Ann Thorac Surg. 2013 Jul; 96(1):311-3. PMID: 23816085.
    Citations: 1     Fields:    Translation:Humans
  45. Kuter DJ, Mehta A, Hollak CE, Giraldo P, Hughes D, Belmatoug N, Brand M, Muller A, Schaaf B, Giorgino R, Zimran A. Miglustat therapy in type 1 Gaucher disease: clinical and safety outcomes in a multicenter retrospective cohort study. Blood Cells Mol Dis. 2013 Aug; 51(2):116-24. PMID: 23683771.
    Citations: 14     Fields:    Translation:Humans
  46. Nsumiwa S, Kuter D, Wittlin S, Chibale K, Egan TJ. Structure-activity relationships for ferriprotoporphyrin IX association and ß-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods. Bioorg Med Chem. 2013 Jul 01; 21(13):3738-48. PMID: 23669191.
    Citations:    Fields:    Translation:HumansAnimals
  47. Egan TJ, Kuter D. Dual-functioning antimalarials that inhibit the chloroquine-resistance transporter. Future Microbiol. 2013 Apr; 8(4):475-89. PMID: 23534360.
    Citations:    Fields:    Translation:HumansAnimals
  48. Kuter DJ, Bussel JB, Newland A, Baker RI, Lyons RM, Wasser J, Viallard JF, Macik G, Rummel M, Nie K, Jun S. Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy. Br J Haematol. 2013 May; 161(3):411-23. PMID: 23432528.
    Citations: 36     Fields:    Translation:HumansCTClinical Trials
  49. Kuter D, Venter GA, Naidoo KJ, Egan TJ. Experimental and time-dependent density functional theory characterization of the UV-visible spectra of monomeric and µ-oxo dimeric ferriprotoporphyrin IX. Inorg Chem. 2012 Oct 01; 51(19):10233-50. PMID: 22963249.
    Citations: 1     Fields:    Translation:Cells
  50. Schulman S, Awad MM, Kuter DJ. Neutrophil-erythrocyte rosettes in autoimmune hemolytic anemia. Am J Hematol. 2013 Apr; 88(4):333-4. PMID: 22886729.
    Citations: 1     Fields:    Translation:HumansCells
  51. Colwell AS, Reish RG, Kuter DJ, Damjanovic B, Austen WG, Fogerty AE. Abdominal contouring procedures increase activity of the coagulation cascade. Ann Plast Surg. 2012 Aug; 69(2):129-33. PMID: 21734537.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  52. Kuter DJ, Mathias SD, Rummel M, Mandanas R, Giagounidis AA, Wang X, Deuson RR. Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care. Am J Hematol. 2012 May; 87(5):558-61. PMID: 22460421.
    Citations: 9     Fields:    Translation:Humans
  53. Alonzo MT, Lacuesta TL, Dimaano EM, Kurosu T, Suarez LA, Mapua CA, Akeda Y, Matias RR, Kuter DJ, Nagata S, Natividad FF, Oishi K. Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections. J Infect Dis. 2012 Apr 15; 205(8):1321-9. PMID: 22383677.
    Citations: 22     Fields:    Translation:HumansCells
  54. Kuter DJ. What is the potential for thrombopoietic agents in acute leukemia? Best Pract Res Clin Haematol. 2011 Dec; 24(4):553-8. PMID: 22127320.
    Citations: 1     Fields:    Translation:HumansCells
  55. Reddy P, Atay JK, Selbovitz LG, Connors JM, Piazza G, Block CC, Arpino PA, Berliner N, Hutter AM, Fischer MA, Kuter D, Weitzman J, Sherwood GK, Almozlino A, Giugliano RP. Dabigatran: a review of clinical and pharmacoeconomic evidence. Crit Pathw Cardiol. 2011 Sep; 10(3):117-27. PMID: 21989032.
    Citations: 7     Fields:    Translation:Humans
  56. Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Steensma DP, Vadhan-Raj S, Westervelt P, Westmoreland M. Myeloid growth factors. J Natl Compr Canc Netw. 2011 Aug 01; 9(8):914-32. PMID: 21900221.
    Citations: 14     Fields:    Translation:Humans
  57. Belmatoug N, Burlina A, Giraldo P, Hendriksz CJ, Kuter DJ, Mengel E, Pastores GM. Gastrointestinal disturbances and their management in miglustat-treated patients. J Inherit Metab Dis. 2011 Oct; 34(5):991-1001. PMID: 21779792.
    Citations: 22     Fields:    Translation:Humans
  58. Kuter D, Chibale K, Egan TJ. Linear free energy relationships predict coordination and p-stacking interactions of small molecules with ferriprotoporphyrin IX. J Inorg Biochem. 2011 May; 105(5):684-92. PMID: 21450272.
    Citations: 3     Fields:    Translation:Cells
  59. Dubar F, Egan TJ, Pradines B, Kuter D, Ncokazi KK, Forge D, Paul JF, Pierrot C, Kalamou H, Khalife J, Buisine E, Rogier C, Vezin H, Forfar I, Slomianny C, Trivelli X, Kapishnikov S, Leiserowitz L, Dive D, Biot C. The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance. ACS Chem Biol. 2011 Mar 18; 6(3):275-87. PMID: 21162558.
    Citations: 23     Fields:    Translation:AnimalsCells
  60. Kuter DJ. Romiplostim. Cancer Treat Res. 2011; 157:267-88. PMID: 21052962.
    Citations: 5     Fields:    Translation:Humans
  61. Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB. The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. J Thromb Haemost. 2010 Dec; 8(12):2642-50. PMID: 20854372.
    Citations: 41     Fields:    Translation:Humans
  62. Kuter DJ, Rummel M, Boccia R, Macik BG, Pabinger I, Selleslag D, Rodeghiero F, Chong BH, Wang X, Berger DP. Romiplostim or standard of care in patients with immune thrombocytopenia. N Engl J Med. 2010 Nov 11; 363(20):1889-99. PMID: 21067381.
    Citations: 64     Fields:    Translation:Humans
  63. Lennerz JK, Kuter DJ, Hasserjian R, Iafrate J. Massive hepatomegaly and involvement by Janus Kinase 2-positive myeloproliferative neoplasm. Hepatology. 2010 Nov; 52(5):1855-6. PMID: 20890944.
    Citations:    Fields:    Translation:Humans
  64. Davids MS, Murali MR, Kuter DJ. Serum free light chain analysis. Am J Hematol. 2010 Oct; 85(10):787-90. PMID: 20721885.
    Citations: 5     Fields:    Translation:HumansCells
  65. Rabin DU, Kuter DJ, Liebman HA, Bussel JB. What do healthcare providers ask their patients with immune thrombocytopenia? Am J Hematol. 2010 Aug; 85(8):629-31. PMID: 20658595.
    Citations:    Fields:    Translation:Humans
  66. Kuter DJ. Biology and chemistry of thrombopoietic agents. Semin Hematol. 2010 Jul; 47(3):243-8. PMID: 20620435.
    Citations: 15     Fields:    Translation:HumansCells
  67. Bussel JB, Kuter DJ. New thrombopoietic agents: introduction. Semin Hematol. 2010 Jul; 47(3):211. PMID: 20620430.
    Citations: 4     Fields:    Translation:Humans
  68. Fleischmann KH, Kuter DJ, Coley CM, Rathmell JP. Practice guidelines often fail to keep pace with the rapid evolution of medicine: a call for clinicians to remain vigilant and revisit their own practice patterns. Reg Anesth Pain Med. 2010 Jan-Feb; 35(1):4-7. PMID: 20048651.
    Citations:    Fields:    Translation:Humans
  69. Kuter DJ, Gernsheimer TB. Thrombopoietin and platelet production in chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009 Dec; 23(6):1193-211. PMID: 19932428.
    Citations: 5     Fields:    Translation:HumansCells
  70. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010 Jan 14; 115(2):168-86. PMID: 19846889.
    Citations: 276     Fields:    Translation:Humans
  71. Kuter DJ, Mufti GJ, Bain BJ, Hasserjian RP, Davis W, Rutstein M. Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim. Blood. 2009 Oct 29; 114(18):3748-56. PMID: 19671919.
    Citations: 42     Fields:    Translation:HumansAnimals
  72. Corrêa Soares JB, Menezes D, Vannier-Santos MA, Ferreira-Pereira A, Almeida GT, Venancio TM, Verjovski-Almeida S, Zishiri VK, Kuter D, Hunter R, Egan TJ, Oliveira MF. Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols. PLoS Negl Trop Dis. 2009 Jul 14; 3(7):e477. PMID: 19597543.
    Citations: 24     Fields:    Translation:Animals
  73. Richardson PG, Xie W, Mitsiades C, Chanan-Khan AA, Lonial S, Hassoun H, Avigan DE, Oaklander AL, Kuter DJ, Wen PY, Kesari S, Briemberg HR, Schlossman RL, Munshi NC, Heffner LT, Doss D, Esseltine DL, Weller E, Anderson KC, Amato AA. Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J Clin Oncol. 2009 Jul 20; 27(21):3518-25. PMID: 19528374.
    Citations: 53     Fields:    Translation:Humans
  74. Davis AK, Makar RS, Stowell CP, Kuter DJ, Dzik WH. ADAMTS13 binds to CD36: a potential mechanism for platelet and endothelial localization of ADAMTS13. Transfusion. 2009 Feb; 49(2):206-13. PMID: 19389207.
    Citations: 9     Fields:    Translation:HumansCells
  75. Kuter DJ. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med. 2009; 60:193-206. PMID: 19642221.
    Citations: 41     Fields:    Translation:Humans
  76. Kuter DJ. New thrombopoietic growth factors. Clin Lymphoma Myeloma. 2009; 9 Suppl 3:S347-56. PMID: 19778863.
    Citations: 7     Fields:    Translation:Humans
  77. Crawford J, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J, Freifeld AG, Goemann M, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, Michaud LB, Miyata SC, Tallman MS, Vadhan-Raj S, Westervelt P, Wong MK. Myeloid growth factors. J Natl Compr Canc Netw. 2009 Jan; 7(1):64-83. PMID: 19176207.
    Citations: 8     Fields:    Translation:Humans
  78. Soupir CP, Vergilio JA, Kelly E, Dal Cin P, Kuter D, Hasserjian RP. Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura. Br J Haematol. 2009 Mar; 144(5):800-2. PMID: 19055669.
    Citations: 4     Fields:    Translation:HumansCells
  79. Bussel JB, Kuter DJ, Pullarkat V, Lyons RM, Guo M, Nichol JL. Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP. Blood. 2009 Mar 05; 113(10):2161-71. PMID: 18981291.
    Citations: 58     Fields:    Translation:HumansCellsCTClinical Trials
  80. McCullough J, Kahn J, Adamson J, Anderlini P, Benjamin R, Confer D, Eapen M, Hirsch B, Kuter D, Lazarus E, Pamphilon D, Stroncek D, Sugarman J, Wilson R. Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues. Transfusion. 2008 Sep; 48(9):2008-25. PMID: 18564401.
    Citations: 8     Fields:    Translation:Humans
  81. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008 Feb 02; 371(9610):395-403. PMID: 18242413.
    Citations: 138     Fields:    Translation:Humans
  82. Kuter DJ. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura. Eur J Haematol Suppl. 2008 Feb; (69):9-18. PMID: 18211568.
    Citations: 7     Fields:    Translation:HumansCells
  83. Kuter DJ. Meeting the treatment challenges of chronic immune thrombocytopenic purpura. Eur J Haematol Suppl. 2008 Feb; (69):1-2. PMID: 18211566.
    Citations:    Fields:    Translation:HumansCells
  84. Nugmanova A, Pillai G, Nugmanova D, Kuter D. Improving the management of hypertension in Kazakhstan: implications for improving clinical practice, patient behaviours and health outcomes. Glob Public Health. 2008; 3(2):214-31. PMID: 19288372.
    Citations: 2     Fields:    Translation:Humans
  85. Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol. 2007 Nov; 139(3):351-62. PMID: 17910625.
    Citations: 57     Fields:    Translation:HumansCells
  86. Park JH, Spitzer T, Kuter DJ. Successful treatment of pure red cell aplasia with autologous stem cell transplantation. Am J Hematol. 2007 Sep; 82(9):812-4. PMID: 17546635.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  87. Moore A, Lau E, Yang C, Mackool B, Kuter DJ. Dalteparin-induced skin necrosis in a patient with metastatic lung adenocarcinoma. Am J Clin Oncol. 2007 Jun; 30(3):329-31. PMID: 17551316.
    Citations:    Fields:    Translation:Humans
  88. Kuter DJ. New thrombopoietic growth factors. Blood. 2007 Jun 01; 109(11):4607-16. PMID: 17289815.
    Citations: 44     Fields:    Translation:HumansCells
  89. Bussel JB, Kuter DJ, George JN, McMillan R, Aledort LM, Conklin GT, Lichtin AE, Lyons RM, Nieva J, Wasser JS, Wiznitzer I, Kelly R, Chen CF, Nichol JL. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med. 2006 Oct 19; 355(16):1672-81. PMID: 17050891.
    Citations: 78     Fields:    Translation:HumansCTClinical Trials
  90. Bennett CL, Evens AM, Andritsos LA, Balasubramanian L, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS. Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol. 2006 Dec; 135(5):642-50. PMID: 17054431.
    Citations: 20     Fields:    Translation:Humans
  91. Lyons AE, Balasubramanian L, Andritsos LA, Evens A, Kuzel T, Vose JM, Bierman PJ, Kuter DJ, Devine SM, Bennett CL. Hematologic malignancies developing in previously healthy individuals who received hematopoietic growth factors: Implications for use of colony stimulating factors in healthy volunteers participating in early phase clinical studies and in healthy blood product donors. J Clin Oncol. 2006 Jun 20; 24(18_suppl):2559. PMID: 27954875.
    Citations:    
  92. Yee AJ, Kuter DJ. Successful recovery after an overdose of argatroban. Ann Pharmacother. 2006 Feb; 40(2):336-9. PMID: 16449547.
    Citations: 3     Fields:    Translation:Humans
  93. Abel GA, Hays JT, Decker PA, Croghan GA, Kuter DJ, Rigotti NA. Effects of biochemically confirmed smoking cessation on white blood cell count. Mayo Clin Proc. 2005 Aug; 80(8):1022-8. PMID: 16092581.
    Citations: 6     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  94. Kuter DJ. The promise of thrombopoietins in the treatment of ITP. Clin Adv Hematol Oncol. 2005 Jun; 3(6):464-6. PMID: 16167023.
    Citations:    Fields:    
  95. Mogues T, Li J, Coburn J, Kuter DJ. IgG antibodies against bovine serum albumin in humans--their prevalence and response to exposure to bovine serum albumin. J Immunol Methods. 2005 May; 300(1-2):1-11. PMID: 15890355.
    Citations: 6     Fields:    Translation:HumansAnimalsCTClinical Trials
  96. Rosovsky RP, Kuter DJ. Catheter-related thrombosis in cancer patients: pathophysiology, diagnosis, and management. Hematol Oncol Clin North Am. 2005 Feb; 19(1):183-202, vii. PMID: 15639113.
    Citations: 10     Fields:    Translation:Humans
  97. Valeri CR, Ragno G, Marks PW, Kuter DJ, Rosenberg RD, Stossel TP. Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(beta-aminoethyl ether) N,N'-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4 degrees C for as long as 5 days. Transfusion. 2004 Jun; 44(6):865-70. PMID: 15157253.
    Citations: 3     Fields:    Translation:AnimalsCells
  98. Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist. 2004; 9(2):207-16. PMID: 15047925.
    Citations: 28     Fields:    Translation:Humans
  99. Nasraway SA, Shorr AF, Kuter DJ, O'Grady N, Le VH, Cammarata SK. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use. Clin Infect Dis. 2003 Dec 15; 37(12):1609-16. PMID: 14689341.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  100. Bertino AM, Qi XQ, Li J, Xia Y, Kuter DJ. Apoptotic markers are increased in platelets stored at 37 degrees C. Transfusion. 2003 Jul; 43(7):857-66. PMID: 12823744.
    Citations: 16     Fields:    Translation:HumansCells
  101. Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med. 2003 Jun 26; 348(26):2609-17. PMID: 12826635.
    Citations: 559     Fields:    Translation:HumansCTClinical Trials
  102. Kuter DJ, Begley CG. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood. 2002 Nov 15; 100(10):3457-69. PMID: 12411315.
    Citations: 62     Fields:    Translation:HumansAnimalsCells
  103. Kuter DJ. Apoptosis in platelets during ex vivo storage. Vox Sang. 2002 Aug; 83 Suppl 1:311-3. PMID: 12617160.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  104. Gerson SL, Kaplan SL, Bruss JB, Le V, Arellano FM, Hafkin B, Kuter DJ. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother. 2002 Aug; 46(8):2723-6. PMID: 12121967.
    Citations: 53     Fields:    Translation:Humans
  105. Kakkar AK, Levine MN, Prandoni P, Lee AY, Rasmussen MS, Kuter D. What is the role for antithrombotics in cancer care? Interactive session with panel discussion. Cancer Treat Rev. 2002 Jun; 28(3):157-9. PMID: 12234568.
    Citations:    Fields:    Translation:HumansPHPublic Health
  106. Kuter DJ. Whatever happened to thrombopoietin? Transfusion. 2002 Mar; 42(3):279-83. PMID: 11961230.
    Citations: 5     Fields:    Translation:HumansCells
  107. Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M, Kuter DJ. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood. 2001 Dec 01; 98(12):3241-8. PMID: 11719360.
    Citations: 103     Fields:    Translation:HumansCells
  108. Li J, Kuter DJ. The end is just the beginning: megakaryocyte apoptosis and platelet release. Int J Hematol. 2001 Dec; 74(4):365-74. PMID: 11794690.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  109. Goodnough LT, Kuter DJ, McCullough J, Slichter SJ, DiPersio J, Romo J, Peterson R, Smith KJ, Raife T, Tomita D, Armstrong S. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood. 2001 Sep 01; 98(5):1346-51. PMID: 11520781.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  110. Kuter DJ, Goodnough LT, Romo J, DiPersio J, Peterson R, Tomita D, Sheridan W, McCullough J. Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood. 2001 Sep 01; 98(5):1339-45. PMID: 11520780.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  111. Kuter DJ, Tillotson GS. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid. Pharmacotherapy. 2001 Aug; 21(8):1010-3. PMID: 11718489.
    Citations: 24     Fields:    Translation:Humans
  112. Brown JR, Kuter DJ. The effect of unfractionated vs. low molecular weight heparin on tissue factor pathway inhibitor levels in hospital inpatients. Thromb Haemost. 2001 Jun; 85(6):979-85. PMID: 11434705.
    Citations: 1     Fields:    Translation:Humans
  113. Glaspy J, Jadeja JS, Justice G, Kessler J, Richards D, Schwartzberg L, Rigas J, Kuter D, Harmon D, Prow D, Demetri G, Gordon D, Arseneau J, Saven A, Hynes H, Boccia R, O'Byrne J, Colowick AB. A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy. Br J Cancer. 2001 Apr; 84 Suppl 1:17-23. PMID: 11308270.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  114. Allgood GS, Kuter DJ, Roll KT, Taylor SL, Zorich NL. Postmarketing surveillance of new food ingredients: results from the program with the fat replacer olestra. Regul Toxicol Pharmacol. 2001 Apr; 33(2):224-33. PMID: 11350205.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  115. Li J, Xia Y, Kuter DJ. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia. Br J Haematol. 2000 Dec; 111(3):943-53. PMID: 11122159.
    Citations: 7     Fields:    Translation:HumansCells
  116. Li J, Xia Y, Bertino AM, Coburn JP, Kuter DJ. The mechanism of apoptosis in human platelets during storage. Transfusion. 2000 Nov; 40(11):1320-9. PMID: 11099659.
    Citations: 18     Fields:    Translation:HumansCells
  117. Xia Y, Li J, Bertino A, Kuter DJ. Thrombopoietin and the TPO receptorduring platelet storage. Transfusion. 2000 Aug; 40(8):976-87. PMID: 10960526.
    Citations: 1     Fields:    Translation:HumansCells
  118. Li J, Sabath DF, Kuter DJ. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets. Cytokine. 2000 Jul; 12(7):835-44. PMID: 10880227.
    Citations: 4     Fields:    Translation:HumansCells
  119. Kuter DJ. Future directions with platelet growth factors. Semin Hematol. 2000 Apr; 37(2 Suppl 4):41-9. PMID: 10831288.
    Citations: 5     Fields:    Translation:HumansAnimals
  120. Snyder EL, Kuter DJ. Apoptosis in transfusion medicine: of death and dying--is that all there is? Transfusion. 2000 Feb; 40(2):135-8. PMID: 10685996.
    Citations: 2     Fields:    Translation:HumansCells
  121. Li J, Xia Y, Kuter DJ. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. Br J Haematol. 1999 Aug; 106(2):345-56. PMID: 10460590.
    Citations: 23     Fields:    Translation:HumansCells
  122. Yang C, Li YC, Kuter DJ. The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat. Br J Haematol. 1999 May; 105(2):478-85. PMID: 10233424.
    Citations: 13     Fields:    Translation:AnimalsCells
  123. Kuter DJ, Cebon J, Harker LA, Petz LD, McCullough J. Platelet growth factors: potential impact on transfusion medicine. Transfusion. 1999 Mar; 39(3):321-32. PMID: 10204598.
    Citations:    Fields:    Translation:HumansAnimalsCells
  124. Letai A, Kuter DJ. Cancer, coagulation, and anticoagulation. Oncologist. 1999; 4(6):443-9. PMID: 10631688.
    Citations: 9     Fields:    Translation:Humans
  125. Vonderheide RH, Thadhani R, Kuter DJ. Association of thrombocytopenia with the use of intra-aortic balloon pumps. Am J Med. 1998 Jul; 105(1):27-32. PMID: 9688018.
    Citations: 4     Fields:    Translation:Humans
  126. Goodnough LT, Kuter D, McCullough J, Brecher ME. Apheresis platelets: emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose. J Clin Apher. 1998; 13(3):114-9. PMID: 9828021.
    Citations: 2     Fields:    Translation:Humans
  127. Kuter DJ. Thrombopoietins and thrombopoiesis: a clinical perspective. Vox Sang. 1998; 74 Suppl 2:75-85. PMID: 9704427.
    Citations: 2     Fields:    Translation:Humans
  128. Kuter DJ. The use of PEG-rhuMGDF in platelet apheresis. Stem Cells. 1998; 16 Suppl 2:231-42. PMID: 11012195.
    Citations: 1     Fields:    Translation:Humans
  129. Kuter DJ. Cover art: the watercolor drawings of James Homer Wright. Stem Cells. 1998; 16 Suppl 2:ix-x. PMID: 11012170.
    Citations:    Fields:    Translation:Cells
  130. Murphy J, Kuter DJ. Trombopoietin: from molecule to medicine. Preface. Stem Cells. 1998; 16 Suppl 2:xi-xii. PMID: 11012171.
    Citations:    Fields:    Translation:HumansAnimals
  131. Head CA, Brugnara C, Martinez-Ruiz R, Kacmarek RM, Bridges KR, Kuter D, Bloch KD, Zapol WM. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo. J Clin Invest. 1997 Sep 01; 100(5):1193-8. PMID: 9276736.
    Citations: 20     Fields:    Translation:HumansCells
  132. Sheridan WP, Kuter DJ. Mechanism of action and clinical trials of Mpl ligand. Curr Opin Hematol. 1997 Sep; 4(5):312-6. PMID: 9288463.
    Citations:    Fields:    Translation:HumansCells
  133. Sirois MG, Simons M, Kuter DJ, Rosenberg RD, Edelman ER. Rat arterial wall retains myointimal hyperplastic potential long after arterial injury. Circulation. 1997 Aug 19; 96(4):1291-8. PMID: 9286961.
    Citations: 5     Fields:    Translation:Animals
  134. Kuter DJ. In vivo effects of Mpl ligand administration and emerging clinical applications for the Mpl ligands. Curr Opin Hematol. 1997 May; 4(3):163-70. PMID: 9209831.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  135. Kuter DJ. Thrombopoietin: biology, clinical applications, role in the donor setting. J Clin Apher. 1996; 11(3):149-59. PMID: 8915820.
    Citations: 1     Fields:    Translation:HumansAnimals
  136. Kuter DJ. The physiology of platelet production. Stem Cells. 1996; 14 Suppl 1:88-101. PMID: 11012207.
    Citations: 16     Fields:    Translation:HumansAnimalsCells
  137. Kuter DJ. Thrombopoietin: Biology and Clinical Applications. Oncologist. 1996; 1(1 & 2):98-106. PMID: 10387974.
    Citations: 6     Fields:    
  138. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood. 1995 May 15; 85(10):2720-30. PMID: 7742532.
    Citations: 41     Fields:    Translation:AnimalsCells
  139. Ravid K, Kuter DJ, Rosenberg RD. rmIL-6 stimulates the transcriptional activity of the rat PF4 gene. Exp Hematol. 1995 May; 23(5):397-401. PMID: 7720812.
    Citations:    Fields:    Translation:HumansAnimalsCells
  140. Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci U S A. 1994 Nov 08; 91(23):11104-8. PMID: 7972018.
    Citations: 42     Fields:    Translation:AnimalsCells
  141. Kuter DJ, Rosenberg RD. Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit. Blood. 1994 Sep 01; 84(5):1464-72. PMID: 8068941.
    Citations: 6     Fields:    Translation:AnimalsCells
  142. Ravid K, Kuter DJ, Beeler DL, Doi T, Rosenberg RD. Selection of an HEL-derived cell line expressing high levels of platelet factor 4. Blood. 1993 Jun 01; 81(11):2885-90. PMID: 8499627.
    Citations: 2     Fields:    Translation:HumansCells
  143. Kuter DJ, Gminski D, Rosenberg RD. Botrocetin agglutination of rat megakaryocytes: a rapid method for megakaryocyte isolation. Exp Hematol. 1992 Oct; 20(9):1085-9. PMID: 1468542.
    Citations:    Fields:    Translation:AnimalsCells
  144. Kuter DJ, Gminski DM, Rosenberg RD. Transforming growth factor beta inhibits megakaryocyte growth and endomitosis. Blood. 1992 Feb 01; 79(3):619-26. PMID: 1732007.
    Citations: 7     Fields:    Translation:AnimalsCells
  145. Ravid K, Doi T, Beeler DL, Kuter DJ, Rosenberg RD. Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site. Mol Cell Biol. 1991 Dec; 11(12):6116-27. PMID: 1944279.
    Citations: 23     Fields:    Translation:HumansAnimalsCells
  146. Kuter DJ, Gminski D, Rosenberg RD. Platelets contain several inhibitors of megakaryocyte growth and ploidization. Prog Clin Biol Res. 1990; 356:245-57. PMID: 2217441.
    Citations:    Fields:    Translation:AnimalsCells
  147. Kuter DJ, Rosenberg RD. Regulation of megakaryocyte ploidy in vivo in the rat. Blood. 1990 Jan 01; 75(1):74-81. PMID: 2294997.
    Citations: 5     Fields:    Translation:AnimalsCells
  148. Kuter DJ, Greenberg SM, Rosenberg RD. Analysis of megakaryocyte ploidy in rat bone marrow cultures. Blood. 1989 Nov 01; 74(6):1952-62. PMID: 2679913.
    Citations: 5     Fields:    Translation:AnimalsCells
  149. Bell DF, Harris WH, Kuter DJ, Wessinger SJ. Elevated partial thromboplastin time as an indicator of hemorrhagic risk in postoperative patients on warfarin prophylaxis. J Arthroplasty. 1988; 3(2):181-4. PMID: 3397749.
    Citations:    Fields:    Translation:Humans
  150. Greenberg SM, Kuter DJ, Rosenberg RD. In vitro stimulation of megakaryocyte maturation by megakaryocyte stimulatory factor. J Biol Chem. 1987 Mar 05; 262(7):3269-77. PMID: 3546304.
    Citations: 5     Fields:    Translation:AnimalsCells
  151. Kuter DJ, Rodgers A. The protein composition of HeLa ribosomal subunits and nucleolar precursor particles. Exp Cell Res. 1976 Oct 01; 102(1):205-12. PMID: 976341.
    Citations: 2     Fields:    Translation:Cells
  152. Kuter DJ, Rodgers A. Ribosomal protein differences between animal cells. Exp Cell Res. 1974 Jul; 87(1):186-94. PMID: 4366854.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  153. Weber K, Kuter DJ. Reversible denaturation of enzymes by sodium dodecyl sulfate. J Biol Chem. 1971 Jul 25; 246(14):4504-9. PMID: 5106387.
    Citations: 77     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kuter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (573)
Explore
_
Co-Authors (69)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.